Could 2 HPV shots be enough? new study tests simpler vaccine schedule
NCT ID NCT04206813
First seen Jan 29, 2026 · Last updated May 21, 2026 · Updated 18 times
Summary
This study looks at whether two doses of the HPV vaccine (Gardasil 9) can protect women aged 16 to 45 as well as the standard three-dose schedule. About 352 women from Boston Medical Center are taking part. Researchers will measure antibody levels in the blood to compare immune responses. If successful, a two-dose regimen could make it easier for more women to get protected against HPV-related cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
Conditions
Explore the condition pages connected to this study.